Unproven healthcare will bankrupt America
Sensible Medicine
APRIL 14, 2024
Multiple myeloma drugs can cost $600,000 per year of treatment, but if MRD is permitted for drug approval, I suspect we will see a deluge of uncertain drugs added to the roster, and the costs per year per patient will swell to a million dollars or more. The patient advocates— whose organizations are often funded by drug companies.
Let's personalize your content